Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Journal of Medical Genetics
|
March 19, 2002
Organisation of the pericentromeric region of chromosome 15: at least four partial gene copies are amplified in patients with a proximal duplication of 15q
J A Fantes, S K Mewborn, C M Lese, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 10, 1999
CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells
J Morales, B Homey, A P Vicari, et al.
Lancet (London, England)
|
July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer
|
August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
A Szarewski, W A J Poppe, S R Skinner, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Journal of Medical Genetics
|
March 19, 2002
Organisation of the pericentromeric region of chromosome 15: at least four partial gene copies are amplified in patients with a proximal duplication of 15q
J A Fantes, S K Mewborn, C M Lese, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 10, 1999
CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells
J Morales, B Homey, A P Vicari, et al.
Lancet (London, England)
|
July 10, 2009
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J Paavonen, P Naud, J Salmerón, et al.
International Journal of Cancer
|
August 23, 2011
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
A Szarewski, W A J Poppe, S R Skinner, et al.
Page
of 4